Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Total 13F shares
-
5,665,990
-
Share change
-
+559,122
-
Total reported value
-
$26,717,000
-
Put/Call ratio
-
43%
-
Price per share
-
$4.71
-
Number of holders
-
14
-
Value change
-
+$2,489,526
-
Number of buys
-
6
-
Number of sells
-
7
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q3 2021
As of 30 Sep 2021,
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,665,990 shares.
The largest 10 holders included
Knoll Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., ARK Investment Management LLC, CITADEL ADVISORS LLC, SIMPLEX TRADING, LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and JANE STREET GROUP, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.